Business Description
Hwail Pharm Co Ltd
ISIN : KR7061250007
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 30.71 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.44 | |||||
Interest Coverage | 108.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 8.34 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 32.3 | |||||
3-Year EBITDA Growth Rate | 27.3 | |||||
3-Year EPS without NRI Growth Rate | -22.9 | |||||
3-Year Book Growth Rate | 1.3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.38 | |||||
9-Day RSI | 41.41 | |||||
14-Day RSI | 40.75 | |||||
6-1 Month Momentum % | -13.65 | |||||
12-1 Month Momentum % | -15.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 12.39 | |||||
Quick Ratio | 9.17 | |||||
Cash Ratio | 6.52 | |||||
Days Inventory | 117.69 | |||||
Days Sales Outstanding | 82.67 | |||||
Days Payable | 13.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.3 | |||||
Shareholder Yield % | 1.59 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 9.4 | |||||
Operating Margin % | 1.67 | |||||
Net Margin % | 3.15 | |||||
FCF Margin % | 4.02 | |||||
ROE % | 2.19 | |||||
ROA % | 2.07 | |||||
ROIC % | 1.39 | |||||
ROC (Joel Greenblatt) % | 5.51 | |||||
ROCE % | 2.78 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 26.87 | |||||
PE Ratio without NRI | 156.16 | |||||
Shiller PE Ratio | 19.98 | |||||
PS Ratio | 0.85 | |||||
PB Ratio | 0.59 | |||||
Price-to-Tangible-Book | 0.59 | |||||
Price-to-Free-Cash-Flow | 19.07 | |||||
Price-to-Operating-Cash-Flow | 13.68 | |||||
EV-to-EBIT | 9.88 | |||||
EV-to-EBITDA | 9.14 | |||||
EV-to-Revenue | 0.4 | |||||
EV-to-FCF | 10.12 | |||||
Price-to-Projected-FCF | 0.58 | |||||
Price-to-Median-PS-Value | 0.85 | |||||
Price-to-Graham-Number | 2.02 | |||||
Price-to-Net-Current-Asset-Value | 0.81 | |||||
Price-to-Net-Cash | 1.69 | |||||
Earnings Yield (Greenblatt) % | 10.12 | |||||
FCF Yield % | 4.17 | |||||
Forward Rate of Return (Yacktman) % | -17.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hwail Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 122,541.219 | ||
EPS (TTM) (â‚©) | 59 | ||
Beta | 0.74 | ||
Volatility % | 24.44 | ||
14-Day RSI | 40.75 | ||
14-Day ATR (â‚©) | 34.184803 | ||
20-Day SMA (â‚©) | 1600.5 | ||
12-1 Month Momentum % | -15.89 | ||
52-Week Range (â‚©) | 1550 - 2410 | ||
Shares Outstanding (Mil) | 74.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hwail Pharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hwail Pharm Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Hwail Pharm Co Ltd Frequently Asked Questions
What is Hwail Pharm Co Ltd(XKRX:061250)'s stock price today?
When is next earnings date of Hwail Pharm Co Ltd(XKRX:061250)?
Does Hwail Pharm Co Ltd(XKRX:061250) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |